Rochester Clinical Research is now enrolling adults 50-64 years old for a study evaluating an updated mRNA COVID-19 vaccine.
Covid-19 Vaccine
Age Range:
50 to 64
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This study will help researchers understand how safe the updated vaccine is and how well it protects against current variants of the virus.
The study lasts about 12 months and includes:
- 1 vaccination visit
- A few short follow-up visits or phone calls over the next year
Qualifications
You may qualify if you:
- Are between 50-64 years old
- Have not received a COVID-19 vaccine in the past 5 months
* Other Qualifications may apply
FEATURED STUDIES
Rochester Clinical Research is enrolling adults ages 50 to 64 for a vaccine research study focused on helping prevent C. […]
Rochester Clinical Research (RCR) is enrolling volunteers for a research study testing an investigational pneumococcal vaccine. This study is looking […]
Rochester Clinical Research in Buffalo is conducting a research study focused on Lyme disease prevention.
Rochester Clinical Research is currently enrolling adults in a new smoking cessation research study. This trial is designed to evaluate […]
Rochester Clinical Research is taking part in a new study evaluating an updated COVID-19 vaccine for generally healthy patients ages […]
Rochester Clinical Research is currently enrolling adults 18 years and older for a research study to learn if a series […]